Merck to acquire Caraway Therapeutic
Merck and Caraway Therapeutics announced Tuesday that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to $610 million, including an undisclosed upfront payment as well as conti